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INTRODUCTION
Since finding severe acute respiratory syndrome (SARS) to oc-
cur due to infection by coronaviruses (CoVs),1,2 researchers have 
become more interested in human coronaviruses (HCoVs). 
Along with the outbreak of Middle East Respiratory Syndrome 
(MERS) in the Republic of Korea this year, HCoVs continue to 
impact global health.3,4 There are four respiratory HCoV species: 
229E, NL63, OC43, and HKU1. In particular, subtypes 229E 
and OC43 are known to cause upper respiratory illness with 
relatively mild symptoms or even asymptomatic infections; 
however, these two subtypes still heavily impact the elderly 
and patients with cardiopulmonary disease.5
HCoV infections can occur anytime, anywhere, and in any-
body. However, there are differences in geographic prevalence 
and age specificity. Among the four known respiratory HCoVs, 
typically only one, or at least a predominant type, is found at a 
particular time and in a particular area. In early childhood, OC43 
and NL63 are detected at a younger age and more frequently.5,6 
In the Republic of Korea, a single HCoV infection was detect-
ed every month in 2013, except June through September, in 
Seoul. The most detected virus was rhinovirus, and HCoVs were 
minor pathogens.7 From 2010 to 2012, HCoV-OC43 was the 
most prevalent subtype.8 Interestingly, however, in 2014, HCoV 
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positive rates were lower than in other years, and HCoV caused 
fewer respiratory infections requiring admission, especially in 
children. While studies on HCoVs with lower respiratory tract 
infections (LRTIs) have been conducted in other countries,9-11 
there are no reports on HCoVs affecting LRTIs. In this study, we 
reviewed clinical presentations of HCoV infection during the 
2014 winter season in Korea.
MATERIALS AND METHODS
This study was performed at Severance Children’s Hospital in 
Seoul, Korea. Outpatient clinic, emergency room, and inpatient 
ward data were collected. From October 1 to December 31 in 
2014, 504 patients under the age of 18 years with episodes of re-
spiratory infection received nasopharyngeal swabs. All clinical 
data were collected by retrospective review of an electric medi-
cal record system. 
We defined LRTIs as pneumonia or bronchiolitis. When a pa-
tient had abnormal lung sounds, such as rales or crackles, with 
local infiltration or consolidation on chest X-ray, we diagnosed 
the patient with pneumonia. When lower airway obstruction 
signs, such as wheezing, decreased lung sounds, or chest retrac-
tions, with either a normal or hyperinflation chest X-ray were 
present, we diagnosed the patient with bronchiolitis.
The swab specimens were sent to a virology laboratory in 
the Department of Laboratory Medicine at Yonsei University 
Medical Center for respiratory virus detection. DNA or RNA of 
respiratory viruses was extracted by TANBead Smart LabAss-
ist-32 (BioKett, Taipei, Taiwan). Then the AdvanSureTM Respi-
ratory Virus real-time RT-PCR Kit (LG Life Science, Seoul, Ko-
rea) was used to analyze all 504 samples. Using this kit, we 
were able to detect 14 types of viruses: respiratory syncytial vi-
rus (RSV) types A and B, influenza A and B, parainfluenza 
types 1, 2, and 3, rhinovirus A, metapneumovirus, HCoV-229E, 
HCoV-OC43, HCoV-NL63, and bocavirus. 
 
 
RESULTS
Prevalence of respiratory viruses
A total of 504 nasopharyngeal swab samples were included in 
our study from October 1 to December 31, 2014. The positive 
rate for respiratory viruses was 67.9% (342 of 504 samples). All 
samples, except two that were obtained from expectorated spu-
tum, were collected using nasopharyngeal swabs. During the 
study period, RSV was the most frequently detected virus 
(48.3%), and HCoV was the third most frequently detected virus 
(9.7%) regardless of subtype (Table 1). The peak incidence of 
HCoV in our hospital during the study period was during the 
48th week of 2014, and this was similar to the pattern shown 
in the survey of Korean Centers for Disease Control and Preven-
tion (KCDC; http://www.cdc.go.kr/CDC/info/CdcKrInfo0502.
jsp?menuIds=HOME001-MNU1175-MNU0048-MNU0050) 
(Fig. 1). According to the plot, there was a certain amount of lag 
time between increases in nationwide HCoV infections and 
our hospital’s pediatric LRTIs due to HCoV. 
Among the 342 positive samples, co-infection with two vi-
ruses was present in 71 samples and three viruses in six sam-
ples. When counting the co-infections, samples collected with-
in a 4-week interval with the same result were counted as one 
result. The most frequent co-infection virus with HCoV was 
RSV (Table 2). 
 
Clinical characteristics and diagnosis 
of HCoV-infected children
The most common signs of HCoV infection were fever and 
cough. Wheezing increased when combined with RSV. Gastro-
intestinal symptoms were not common. 
Most of the patients had an abnormal chest X-ray, such as 
pneumonic infiltration, ground glass opacity, air trapping, and 
inter-costal lung herniation. Most of them had a lower respira-
tory tract infection, such as pneumonia, bronchiolitis, or bron-
chitis.
Antibiotics were used in almost all patients, because the viral 
panel result was obtained 2–3 days after admission. A nebulizer 
was less commonly used in the CoV only-infected group. Ste-
roids were used more commonly in the CoV and RSV co-infect-
ed groups (Table 3).
Disease severity of the HCoV-only infected group 
compared to the RSV group 
We compared the fever day, obstruction signs (such as wheez-
ing, chest retraction, and nasal flaring), hospital day (HOD), ste-
roid use, and oxygen supply. As RSV infection is the major cause 
of LRTIs and hospital visits, we compared the selected param-
Table 1. Viruses Identified in 504 Nasopharyngeal Swab Samples Ob-
tained from Patients
Virus Number of detected samples (%)
RSV A 215 (42.7)
RSV B 28 (5.6)
Rhinovirus A, B, C 98 (19.4)
Coronavirus 229E 1 (0.2)
Coronavirus OC43 29 (5.8)
Coronavirus NL63 19 (3.8)
Adenovirus 15 (3.0)
Parainfluenza virus 1 7 (1.4)
Parainfluenza virus 2 0 (0)
Parainfluenza virus 3 1 (0.2)
Bocavirus 7 (1.4)
Influenza virus 4 (0.8)
Metapneumo virus 1 (0.2)
RSV, respiratory syncytial virus.
71 samples had two viruses co-infection and 6 samples had three viruses co-
infection.
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eters between RSV infection and HCoV infection. We did not 
compare the severity between each subtype of HCoV, because 
the patient population size was too small.
There were no differences among the two groups in terms of 
fever days, HOD, and oxygen supplementation. Obstruction 
signs, however, were more prevalent in the RSV only-infection 
group (51.9%) than in the HCoV-only infected group (25%; 
p=0.033). The RSV-infected group used more steroids than the 
HCoV-infected group (p=0.007) (Table 4).
Disease severity of HCoV in the same months of 2013 
and 2014
As a percentage, HCoV among total respiratory viruses in the 
winter season was higher in 2014 than in 2013.
Table 2. Co-Infection Status of Respiratory Viruses
Viruses n (%) Coronavirus OC43 Coronavirus NL63 Coronavirus 229E RSV
Coronavirus 229E 1 (0.2) NA NA NA 1
Coronavirus OC43 29 (5.8) 13 1 NA 10
Coronavirus NL63 19 (3.8) 1 8 NA 8
RSV 243 (48.3) 10 8 1 219
Adenovirus 15 (3.0) 2 NA NA NA
Rhinovirus A, B, C 98 (19.4) 4 1 NA 5
Metapneumovirus 1 (0.2) NA NA NA 1
Bocavirus 7 (1.4) 1 NA NA 1
Influenza virus A 4 (0.8) NA NA NA 1
Influenza virus B 0 (0) NA NA NA NA
PIV 1 7 (1.4) NA 1 NA NA
PIV 2 0 (0) NA NA NA NA
PIV 3 1 (0.2) NA NA NA NA
RSV, respiratory syncytial virus; PIV, parainfluenza virus; HCoV, human coronavirus; NA, not applicable.
One patient with RSV A and RSV B infection, one patient with HCoV-CO43 and HCoV-NL63 infection, one patient with RSV A, HCo-OC43, and rhinovirus, and 
one patient with RSV A, HCo-OC43, and Bocavirus was detected.
Table 3. Symptoms, Signs and Treatment among Patients Infected with HCoV 
Virus composition
Coronavirus only
(n=22)
Coronavirus+RSV
(n=17)
Coronavirus+other  
virus* (n=7)
Coronavirus+RSV+other 
virus† (n=2)
Underlying disease, n (%) 12 (54.5) 1 (5.9) 3 (42.9) 1 (50)
Signs and symptoms, n (%)
Fever 21 (95.5) 15 (88.2) 4 (57.1) 2 (100)
Rash 1 (4.5) 1 (5.9) 0 (0) 0 (0)
Hypotension 0 (0) 0 (0) 0 (0) 0 (0)
Cough 16 (72.7) 17 (100) 6 (85.7) 2 (100)
Sputum 9 (40.9) 8 (47.1) 4 (57.1) 0 (0)
Rhinorrhea 11 (50) 9 (52.9) 3 (42.9) 2 (100)
Diarrhea 2 (9.1) 1 (5.9) 0 (0) 0 (0)
Vomiting 1 (4.5) 1 (5.9) 0 (0) 0 (0)
Wheezing 2 (9.1) 9 (52.9) 2 (28.6) 1 (50)
Chest retraction 1 (4.5) 0 (0) 0 (0) 0 (0)
Chest X-ray, n (%)
Normal 6 (27.3) 0 (0) 0 (0) 0 (0)
Abnormal 15 (68.2) 17 (100) 7 (100) 2 (100)
Not done 1 (4.5) 0 (0) 0 (0) 0 (0)
Treatment, n (%)
Antibiotic use 19 (86.4) 17 (100) 7 (100) 2 (100)
Nebulizer use 14 (63.6) 17 (100) 7 (100) 2 (100)
Steroid use 4 (18.2) 11 (64.7) 1 (14.3) 1 (50)
HCoV, human coronavirus; RSV, respiratory syncytial virus; PIV, parainfluenza virus.
*Other viruses were two adenoviruses, one coronavirus coinfection with OC43 and NL63, one PIV 1, four rhinoviruses, and seven RSVs (six A types and one B 
type), †Other viruses were rhinovirus and bocavirus.
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In 2013, among the total 254 tested samples, 180 samples 
were positive, and among these, 15 samples were positive for 
HCoV. In 2014, among the total 504 tested samples, 342 were 
positive, and among these, 48 samples were positive for HCoV. 
When these parameters were compared, there were no signifi-
cant differences between them (Table 5).
DISCUSSION
Traditionally, CoV has been considered the most common 
cause of upper respiratory tract infection (URTI), which 
causes epidemics every 2–3 years. However, the emergence of 
SARS, caused by a group II CoV, has provided further insight 
that this virus can cause severe respiratory distress that is not 
simply limited to URTIs. In the 2000s, newly identified CoVs, 
HCoVNL63 and HCoV-HKU1, were introduced. CoV is now an 
important pathogen in pediatric infections, not only in URTIs 
but also in LRTIs, such as community-acquired pneumonia 
and bronchiolitis.12-15 
Our data revealed a higher positive rate of total respiratory vi-
ruses.16,17 As our hospital provides tertiary care, the disease sever-
ity of admitted children may be higher than other studies. Fur-
thermore, viral study is performed only in children with sus-
pected lower respiratory tract disease. This may have influenced 
higher detection rate of viruses.
Also, a higher positive rate of co-detection of RSV and CoVs 
was shown. Patterns of co-detection of respiratory virus differ 
from each study. In our report, patterns did not differ signifi-
cantly from other reports.
Previous studies have reported that influenza virus follows 
RSV. However, our study showed that CoV seemed to follow 
RSV, as the influenza season followed an increase in CoV in-
fections during the winter of 2014.
Interestingly in this study, there were no differences in fever 
days or days of hospital stay between RSV and HCoV. RSV is 
traditionally known as the most common cause of LRTIs in 
the winter season, especially in bronchiolitis. Since our hospi-
tal uses steroids to control obstruction symptoms, RSV showed 
more obstruction signs and that is why the RSV-infected group 
used more steroids than the HCoV-infected group. However, 
we expect that the disease courses of RSV and HCoV were simi-
lar in the winter of 2014, because the days of hospital stay and 
fever days were not very different. 
When we compared years 2013 and 2014 in terms of HCoV, 
the parameters we thought could explain the severity of LRTI 
did not differ. While severity itself due to HCoV was similar, LR-
TIs caused by HCoV were much more common in 2014 than in 
Fig. 2. Positive rate of HCoV among respiratory viruses. KCDC, Korean 
Centers for Disease Control and Prevention; Sev, Severance Children’s 
Hospital; HCoV, human coronavirus.
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Fig. 1. Age distribution of HCoV and RSV from children <18 years old of 
age from October 2014 to December 2014. HCoV, human coronavirus; 
RSV, respiratory syncytial virus.
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Table 4. Comparison of Disease Severity between HCoV and RSV in 2014 Winter Season
HCoV only RSV p value*
Total patients 20 234
Age (month) 42.20 (-0.38–84.78) 16.07 (-2.73–34.87) 0.013
Sex (M:F %) 60:40 51.4:48.6 0.462
Fever day (day) 3.45 (1.88–5.02) 2.57(0.15–4.99) 0.112
Obstruction sign 25% 51.9% 0.033
HOD (day) 6.15 (-0.65–12.95) 5.80 (0.21–11.39) 0.792
Steroid use 30% 61.2% 0.007
O2 use 5.0% 11.2% 0.704
HCoV, human coronavirus; RSV, respiratory syncytial virus.
*p value was calculated by Pearson χ2 test.
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2013 (positive rate of HCoV 8.3% vs. 14.0%).
Interestingly, when the data from the Korea CDC showed an 
increase in HCoV, there was no detected HCoV in our pediatric 
patients. After about five weeks, HCoV began to be detected in 
our pediatric patients. It is difficult to determine the reason for 
the delayed HCoV detection in LRTIs, compared to that in gen-
eral lower respiratory infections. This study is based on the re-
spiratory virus infection data of the KCDC, which examines ref-
erences weekly. These references are obtained from the sputum 
of adults and children who visit primary medical centers due 
to respiratory infection symptoms, not only for lower but also 
upper respiratory infection symptoms. This means that those 
viruses are thought to be the pathogens of the upper respirato-
ry infection, as shown in Fig. 2. In general, respiratory viruses 
are spread by children who attend school. They transmit them 
to adults or infants and young children. In light on this result, 
we predict that when respiratory infections due to HCoV in-
crease in primary care settings, as reported weekly by the 
KCDC, lower respiratory infections due to HCoV in children 
will increase within a few weeks.
During the last winter season, HCoV infection was com-
mon during the RSV infection period. Traditionally, RSV has 
been the main cause of bronchiolitis during this season, al-
though, interestingly, HCoV also affected those with a similar 
diagnosis. Similar to other studies, we found the most com-
mon co-infection respiratory virus with HCoV was RSV.18 Ac-
cording to our data, bronchiolitis with airway obstruction is 
due to RSV not HCoV. On the other hand, HCoV induces pneu-
monia rather than bronchiolitis. This result was similar to that 
of previous studies.10,11 Therefore, when caring the lower respi-
ratory tract infection in the season when RSV and HCoV are 
both common, we should predict the causative virus. If bron-
chiolitis is the main presentation, RSV should be predicted, 
and if pneumonia is the main presentation, then HCoV should 
be predicted. 
According to our hospital’s data, the distribution of HCoV 
subtype was not different than in other countries, such as the 
United States and those of Europe.10,11 Regardless of the country, 
HCoV-OC43 and HCoV-NL63 are the main subtypes of HCoV 
for LRTIs. 
In the Republic of Korea, respiratory infections due to CoV 
continue to be present every year. However, since lower respi-
ratory infections due to CoVs were uncommon during the 
winter of 2014, clinicians did not have much interest in it. As 
we experienced last winter, CoV can be a pathogen associated 
with LRTIs of which clinicians should be aware. Although 
HCoV primarily causes URTIs, we should keep in mind that 
HCoV can cause both URTIs and LRTIs.
In conclusion, infections caused by HCoVs are common and 
can cause LRTIs. During an epidemic season, clinicians should 
be given special consideration thereto. When detections of 
HCoV are increasing, according to reports from the KCDC, pe-
diatricians should keep in mind that LRTI due to HCoV will in-
crease in 4–5 weeks. Also, when combined with other medical 
conditions, such as neurologic or cardiologic diseases, ICU care 
may be necessary.
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